Eldcon Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Cuttack Sadar, Orissa, India, established in 2023.
2023 Cuttack Sadar, Orissa, India Active
Last Updated:
Access Report
About Eldcon Pharmaceuticals Private Limited

Eldcon Pharmaceuticals Private Limited, a active private limited company, was established on 30 May 2023 in Cuttack Sadar, Orissa, India. it holds CIN: U46497OD2023PTC042802. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Dillip Kumar Pradhan (Director), Chinmaya Bastia (Director). Its latest AGM occurred on 25 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No - 742/3716, Ground Floor, Kantilo, New Beleswar Colony, Cuttack Sadar, Orissa, 753004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497OD2023PTC042802

  • Registration Number

    042802

  • Incorporation Date

    30 May 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Cuttack

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Eldcon Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eldcon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Eldcon Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dillip Kumar Pradhan Director 30 May 2023 Current
Chinmaya Bastia Director 30 May 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eldcon Pharmaceuticals.

Enhance accessibility to Eldcon Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Eldcon Pharmaceuticals revenue growth over time
Eldcon Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eldcon Pharmaceuticals?

Unlock access to Eldcon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eldcon Pharmaceuticals?

Unlock and access historical data on people associated with Eldcon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eldcon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eldcon Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eldcon Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Eldcon Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Aug 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Eldcon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack. was recorded as a recent event.

  • Director Appointment

    The activity Dillip Kumar Pradhan was appointed as a Director was appointed as a Director on 30 May 2023 & has been associated with this company since 2 years 8 months . was completed.

  • Director Appointment

    Progress on Chinmaya Bastia was appointed as a Director was appointed as a Director on 30 May 2023 & has been associated with this company since 2 years 8 months . was documented.

  • Company Incorporation

    Eldcon Pharmaceuticals Private Limited was registered on 30 May 2023 with Roc Cuttack & aged 2 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eldcon Pharmaceuticals Private Limited?

The CIN of Eldcon Pharmaceuticals Private Limited is U46497OD2023PTC042802.

Where is Eldcon Pharmaceuticals Private Limited headquartered?

Eldcon Pharmaceuticals Private Limited is headquartered at Plot No - 742/3716, Ground Floor, Kantilo, New Beleswar Colony, Cuttack Sadar, Orissa, 753004.

When was Eldcon Pharmaceuticals Private Limited incorporated?

Eldcon Pharmaceuticals Private Limited was incorporated on 30 May 2023.

Who are the current directors of Eldcon Pharmaceuticals Private Limited?

The current directors of Eldcon Pharmaceuticals Private Limited are

Is Eldcon Pharmaceuticals Private Limited a listed company?

Eldcon Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Eldcon Pharmaceuticals Private Limited?

The authorized capital of Eldcon Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available